HLIHoulihan Lokey, Inc.
Is the price fair?
In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In its normal range: P/E 21.8 vs a 16.6 median over 41 quarters (+32% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What HLI's price assumes
Houlihan Lokey, Inc. trades at 21.8× earnings against 19.0× for the median Capital Markets name, more expensive than its own group.
Trailing P/E · Capital Markets median 19.0 · 1.15× the median: the market pays up for this one
- Price / sales
- 3.65
Price / sales · as of 2026-Q2
- Price / book
- 4.09
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 4.09
- Financial Services median P/E625 names
- 12.1
- Capital Markets median P/E49 names
- 19.0
- Market capitalisation
- $9.41B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $79.30 |
| Its own P/E history, median | $98.65 |
| Its own P/E history, upper quartile | $153.95 |
| 52-week range | $123.37 – $206.68 |
| Today | $130.17 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Capital Markets
The closest names by size in the same industry